Prescription-Drug-Spending_Regence

Why we're addressing the growth in medication spending

By Regence | June 16, 2015

Prescription drug costs are making headlines nationwide, from the Wall Street Journal to your local business journal. Historically, we have guided our members to generic versions for cost relief. But relief is getting hard to find.

A snapshot of specialty drug costs shows why. Drawing on data from affiliated plans across the country, the Blue Cross and Blue Shield Association’s “The Health of America” report shows specialty drugs are driving the growth in medication spending. For these drugs, there are no low-cost options.

Specialty drugs for conditions like multiple sclerosis, rheumatoid arthritis, psoriasis and hepatitis C now comprise 23% of all prescription spending – and that segment rose 20% last year.

When there’s only one of a drug, we have limited bargaining power on price. But as Blue plans, together we can use our influence to shift the places they are administered to lower-cost venues.

That’s just one way we advocate for our members to make health costs more affordable and sustainable.

Learn more about The Health of America.

Share:

Recent posts

phishing-prevention-tips-web

Phishing – Don’t get hooked

By Regence
September 19, 2017
At Regence, we’re committed to keeping personal information safe and secure. Check out our quick refresher on what you can do to keep your information safe.
habitat build

Celebrating a milestone by giving back

By Tim Lieb
September 12, 2017
Ho we are supporting 100 non-profits across the region by giving time and resources to our communities.
Lead_1957.64.B2725_0

"The Happiest Fellers": Regence history featured in Seattle Business Magazine

By Regence
September 12, 2017
Regence is rooted in our commitment to our community.